Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
Crossref DOI link: https://doi.org/10.1007/s40261-017-0537-9
Published Online: 2017-06-22
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Panguluri, Srilekha
Gunda, Praveen
Debonnett, Laurie
Hamed, Kamal http://orcid.org/0000-0003-1896-9736
License valid from 2017-06-22